ask="45.40"
ask_size="1000"
average_daily_volume="1024250"
bid="44.05"
bid_size="100"
book_value="4.05"
change="+0.96"
change_from_200_day_moving_average="-2.15"
change_from_50_day_moving_average="1.61"
change_from_52_week_high="-10.15"
change_From_52_week_low="13.75"
change_in_percent="+2.18%"
close="45.00"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.41"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="85928000"
high="45.29"
high_52_weeks="55.15"
last_trade_date="1/9/2017"
last_trade_price="45.00"
last_trade_size="87391"
last_trade_time="4:00pm"
low="44.05"
low_52_weeks="31.25"
market_capitalization="3.91B"
moving_average_200_day="47.15"
moving_average_50_day="43.39"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="68.00"
open="44.50"
pe_ratio="N/A"
peg_ratio="0.72"
percent_change_from_200_day_moving_average="-4.57%"
percent_change_from_50_day_moving_average="+3.71%"
percent_change_from_52_week_high="-18.40%"
percent_change_from_52_week_low="+44.00%"
previous_close="44.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.88"
price_per_sales="255.05"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.97"
stock_exchange="NMS"
symbol="NBIX"
volume="1456989"
weeks_range_52="31.25 - 55.15"
